Literature DB >> 17520242

Current role of LC-MS in therapeutic drug monitoring.

Franck Saint-Marcoux1, François-Ludovic Sauvage, Pierre Marquet.   

Abstract

The role of liquid chromatography coupled with mass spectrometry (LC-MS) techniques in routine therapeutic drug monitoring activity is becoming increasingly important. This paper reviews LC-MS methods published in the last few years for certain classes of drugs subject to therapeutic drug monitoring: immunosuppressants, antifungal drugs, antiretroviral drugs, antidepressants and antipsychotics. For each class of compounds, we focussed on the most interesting methods and evaluated the current role of LC-MS in therapeutic drug monitoring.

Mesh:

Substances:

Year:  2007        PMID: 17520242     DOI: 10.1007/s00216-007-1320-1

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  17 in total

1.  Silica coated paper substrate for paper-spray analysis of therapeutic drugs in dried blood spots.

Authors:  Zhiping Zhang; Wei Xu; Nicholas E Manicke; R Graham Cooks; Zheng Ouyang
Journal:  Anal Chem       Date:  2011-12-23       Impact factor: 6.986

2.  Automated solid-phase microextraction and thin-film microextraction for high-throughput analysis of biological fluids and ligand-receptor binding studies.

Authors:  Dajana Vuckovic; Erasmus Cudjoe; Florin Marcel Musteata; Janusz Pawliszyn
Journal:  Nat Protoc       Date:  2010-01-07       Impact factor: 13.491

Review 3.  Therapeutic drug monitoring for tomorrow.

Authors:  Erik Eliasson; Jonatan D Lindh; Rickard E Malmström; Olof Beck; Marja-Liisa Dahl
Journal:  Eur J Clin Pharmacol       Date:  2013-05-03       Impact factor: 2.953

4.  Nails are a potential alternative matrix to hair for drug analysis in general unknown screenings by liquid-chromatography quadrupole time-of-flight mass spectrometry.

Authors:  Franziska Krumbiegel; Martin Hastedt; Michael Tsokos
Journal:  Forensic Sci Med Pathol       Date:  2014-07-19       Impact factor: 2.007

5.  Drug monitoring: bright lights yield drug readout.

Authors:  Lei Ge; Jinghua Yu
Journal:  Nat Chem Biol       Date:  2014-07       Impact factor: 15.040

6.  Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring.

Authors:  Rudolf Griss; Alberto Schena; Luc Reymond; Luc Patiny; Dominique Werner; Christine E Tinberg; David Baker; Kai Johnsson
Journal:  Nat Chem Biol       Date:  2014-06-08       Impact factor: 15.040

7.  Feasibility of Using High-Contrast Grating as a Point-of-Care Sensor for Therapeutic Drug Monitoring of Immunosuppressants.

Authors:  Yi-Cheng Liu; Christina Thantrakul; Shu Kan; Connie Chang-Hasnain; Dong-Ru Ho
Journal:  IEEE J Transl Eng Health Med       Date:  2020-01-30       Impact factor: 3.316

8.  A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples.

Authors:  Christoph Seger; Karin Tentschert; Wolfgang Stöggl; Andrea Griesmacher; Steven L Ramsay
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 9.  Clinical utility of drug measurement and pharmacokinetics: therapeutic drug monitoring in psychiatry.

Authors:  Christoph Hiemke
Journal:  Eur J Clin Pharmacol       Date:  2008-01-15       Impact factor: 2.953

10.  Feasibility of ribavirin therapeutic drug monitoring in hepatitis C.

Authors:  Francois-Ludovic Sauvage; Francoise Stanke-Labesque; Marie-Claude Gagnieu; Jean-Francois Jourdil; Gerard Babany; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.